DocGo (DCGO) Morgan Stanley 24th Annual Global Healthcare Conference summary
Event summary combining transcript, slides, and related documents.
Morgan Stanley 24th Annual Global Healthcare Conference summary
21 Sep, 2026Business overview and growth strategy
Provides mobile health, medical transportation, and telehealth services across the U.S. and U.K., with 1 million annual telehealth visits and 700,000 patient transports in the past year.
Focuses on chronic condition management, remote monitoring 55,000 patients, and in-home care for 150,000 patients annually.
Integrated tech platform matches clinicians and diagnostics to patient needs, optimizing care delivery both virtually and in-person.
Recent acquisitions, such as PTI and SteadyMD, have expanded capabilities in mobile phlebotomy and virtual care, with strong year-over-year revenue growth.
Market expansion is driven by anchor customers and embedded demand, with a focus on achieving profitability in new geographies.
Profitability and financial targets
Targets adjusted EBITDA positivity by year-end, with $240 million of projected 2026 revenue from currently EBITDA-positive business lines.
Non-profitable service lines are being eliminated or redesigned, with ongoing efforts to optimize the portfolio.
Plans to improve gross margin from 30.5% to 34% by exiting or redesigning underperforming markets.
SG&A reductions include a $3 million quarterly cut, aided by a recent reduction in force and automation initiatives.
Expects to exit the year on a profitable run-rate basis, driven by top-line growth, margin improvement, and cost control.
Technology and operational efficiency
Proprietary tech stack enables efficient routing, clinician assignment, and integration with EHR systems like Epic, streamlining referrals and transportation.
Automation and AI are reducing administrative workload, with 80% of mobile phlebotomy order intake now automated.
Ten automation initiatives are projected to save $6 million in SG&A, supporting scalable growth without proportional staff increases.
Tech-enabled workflows improve patient readiness and hospital efficiency, increasing stickiness with hospital partners.
Latest events from DocGo
- Q2 2026 revenue reached $73.4M, with strong growth and a major virtual care acquisition planned.DCGO
Investor presentation - Q2 2026 revenue fell 8.7% but core lines grew 19% as net loss widened to $18.0M.DCGO
Q2 2026 - Record growth, board transition, and tech-driven initiatives mark a pivotal year.DCGO
AGM 2026 - Transitioning to proactive, tech-enabled care, the company targets growth and profitability.DCGO
Goldman Sachs 47th Annual Global Healthcare Conference 2026 - Tech-driven healthcare platform posts strong growth, raises guidance, and targets profitability.DCGO
21st Annual Needham Technology, Media, & Consumer Conference - Rapidly scaling mobile healthcare and transport with strong growth, tech integration, and expanding margins.DCGO
Investor presentation - Q1 revenue was $75.6M, net loss widened, but 2026 guidance was raised on strong core growth.DCGO
Q1 2026 - Q3 revenue dropped 26%, but net income and adjusted EBITDA rose, with guidance raised.DCGO
Q3 2024 - Q2 revenue up 31% to $164.9M, net income and margins rose, cash flow guidance increased.DCGO
Q2 2024